Mon news: Novo planning Denmark production plant. Study links Ozempic to rare vision loss condition. 3 closely watched drugs that failed in the clinic. Breakthrough status for Sanofi MS drug. Novo Holdings/Catalent deal a go. —http://bit.ly/w28kSd
Cafepharma
Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.
cafepharma